You Can’t Patent LSD
Motley Fool Money
00:00
Intro
This chapter explores the advancements in psychedelic therapies, particularly psilocybin, for treating mental health issues like depression and PTSD. It also examines the ongoing clinical trials, the progress of companies like Compass Pathways and Siben, and the regulatory challenges they face.
Play episode from 00:00
Transcript
